Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05675397

Preterm Donor Human Milk Supplementation of Mother's Own Milk in VLBW Infants

Supplementation of Mother's Own Milk With Preterm Donor Human Milk: Impact on Morbidity and Growth in Very Low Birth Weight Infants

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
National and Kapodistrian University of Athens · Academic / Other
Sex
All
Age
1 Day – 3 Weeks
Healthy volunteers
Not accepted

Summary

This prospective randomized controlled trial aims to investigate whether feeding very low birth weight (VLBW) infants with Mother's own milk (MOM) supplemented with either preterm (PDM) or term donor milk (TDM), when MOM is insufficient, has a positive impact on infants' protein intake, growth and morbidity.

Detailed description

Mother's own milk (MOM) is the optimal nutrition for preterm infants. When MOM is not sufficient, pasteurized donor milk (DM) is the best alternative according to current recommendations. Donor milk is primarily derived from mothers of term-born infants for the first six months of lactation. However, this term milk presents significant differences compared to preterm human milk which has higher protein concentration and more caloric energy. The investigators hypothesized that feeding VLBW infants with preterm donor milk (PDM) in combination with MOM may positively influence the protein intake and, consequently, the infants' growth. The aim of the current study is to assess whether MOM supplementation with PDM has any beneficial effects on the nutrition, growth and morbidity in VLBW infants.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTdonor human milkPasteurized preterm donor milk (PDM) versus term donor milk (TDM) will be provided to the study population following randomization, as supplementary to mother's own milk (MOM) or as alternative feeding

Timeline

Start date
2022-12-01
Primary completion
2026-12-01
Completion
2027-12-01
First posted
2023-01-09
Last updated
2023-01-09

Locations

2 sites across 1 country: Greece

Source: ClinicalTrials.gov record NCT05675397. Inclusion in this directory is not an endorsement.